RB
Insider
Richard A Barasch
DirectorRichard A Barasch (Director) filed 1 Form 4 report in the past 24 months (1 purchase, 0 sales), most often in Starling Oncology Inc (TOI). Across 1 priced purchase filing, the average 21-session return was +152.3% from execution and +164.5% from disclosure (delay-adjusted; derived). The largest single filing was $1.4M of TOI (1,358,448 sh × $1.04, as filed), executed Mar 26 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
+152.3%
avg across 1 priced filings
Delay-adjustediThe same average, entered at disclosure dates
+164.5%
same 1 filings, from disclosure
Filings, ttm
1
1 buys · 0 sells
Median delay
2d
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.4M
shares × price, as filed
Last traded
Mar 26 2025
Filed Mar 28 2025
Median ADV $10.2M across their filed names
Open performance→Volume by month
Buys $1.4M
Sells $0
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
1 filing
Sector per market data · by filing · past 24 months
Most traded names
TOI
Starling Oncology Inc
TOI · 1 buy · 0 sells
1 filing
Recent filings
TOIPURCHASE
Starling Oncology Inc
View filing →
$1.4M1,358,448 sh × $1.04
Exec Mar 26 2025
Filed Mar 28 2025 · 5:30 PM ET